Airnexis Therapeutics Inc
Palo Alto, US · Founded 2024 · Delaware corporation · 11 employees on LinkedIn · 1 known investors
Founders & leadership
JL
James LiExecutive
MF
Maria FardisExecutive
Board
AC
Anna ChenBoard director
CW
Colin WalshBoard director
EC
Evan CaplanBoard director
JC
Jill CarrollinBoard directorOperating Partner - Portfolio Value Creation at SR One Capital Management
Investors · 1
Reported raises · per SEC filings
Form D private placements$62M disclosed across 1 round · 2026
▶$62MraisedMar 2026 · 13 investors · BiotechnologyRule 506(b)
▶$62MraisedMar 2026 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Anna ChenDirector
- Colin WalshDirector
- Evan CaplanDirector
- James LiExecutive Officer, Director
- Jill CarrollDirector
- Maria FardisExecutive Officer, Director
- Offering amount
- $200M
- Amount sold
- $62M
- First sale
- Jan 2026
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Airnexis Therapeutics Inc's investors?
- Airnexis Therapeutics Inc's investors include SR One Capital Management.
- How much funding has Airnexis Therapeutics Inc raised?
- Airnexis Therapeutics Inc has disclosed $62M raised across 1 round.
- Where is Airnexis Therapeutics Inc headquartered?
- Airnexis Therapeutics Inc is headquartered in Palo Alto, US.